Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

NCT00720590 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Endothelial Dysfunction

Interventions

DRUG: Atazanavir
DRUG: Lopinavir/ritonavir
DRUG: Placebo

Sponsor

Indiana University

Collaborators

[object Object]